David C. Hodgson
CIK: 0001193346
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 5, 2026RPRX
Royalty Pharma plc
Award(A)Direct4.5K shares- - May 28, 2026TNET
TRINET GROUP, INC.
Award(A)Direct7.4K shares- - Mar 13, 2026ALHC
Alignment Healthcare, Inc.
Award(A)Direct19K shares- - May 23, 2025TNET
TRINET GROUP, INC.
Award(A)Direct4.1K shares- - May 13, 2025RPRX
Royalty Pharma plc
Award(A)Direct7.6K shares- - Mar 13, 2025ALHC
Alignment Healthcare, Inc.
Award(A)Direct18.7K shares- - Oct 4, 2024TNET
TRINET GROUP, INC.
Award(A)Direct186 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  RPRX Royalty Pharma plc | Award(A) | 4,545 | - | $0 | Direct |
| May 28, 2026 |  TNET TRINET GROUP, INC. | Award(A) | 7,378 | - | $0 | Direct |
| Mar 13, 2026 |  ALHC Alignment Healthcare, Inc. | Award(A) | 18,982 | - | $0 | Direct |
| May 23, 2025 | TNET TRINET GROUP, INC. | Award(A) | 4,127 | - | - | Direct |
| May 13, 2025 | RPRX Royalty Pharma plc | Award(A) | 7,614 | - | - | Direct |
| Mar 13, 2025 | ALHC Alignment Healthcare, Inc. | Award(A) | 18,710 | - | - | Direct |
| Oct 4, 2024 | TNET TRINET GROUP, INC. | Award(A) | 186 | - | $0 | Direct |
1-7 of 7 transactions
About HODGSON DAVID C
HODGSON DAVID C (SEC CIK 0001193346) files insider reports with the SEC as Director of Royalty Pharma plc (RPRX), Director of TRINET GROUP, INC. (TNET) and Director of Alignment Healthcare, Inc. (ALHC).
Signal8 holds 7 ownership filings by HODGSON DAVID C, all Form 4s, filed between Oct 8, 2024 and Jun 8, 2026. Those filings report 7 transactions, from Oct 4, 2024 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HODGSON DAVID C's filings is in DUBLIN, CA.
Recent filings by HODGSON DAVID C
- Jun 5, 2026: Grant or award of RPRX shares (Form 4, code A).
- May 28, 2026: Grant or award of TNET shares (Form 4, code A).
- Mar 13, 2026: Grant or award of ALHC shares (Form 4, code A).
- May 23, 2025: Grant or award of TNET shares (Form 4, code A).
- May 13, 2025: Grant or award of RPRX shares (Form 4, code A).
Other insiders filing for Royalty Pharma plc (RPRX)
- Urist Marshall, EVP, Research & Investments
- Bassler Bonnie L, Director
- Hite Christopher, EVP & Chairman, Partnering
- Coyne Terrance P., EVP & CFO
- Legorreta Pablo G., CEO, Chairman of the Board
- WEATHERMAN ELIZABETH H, Director